Ignite Creation Date:
2024-05-06 @ 11:22 AM
Last Modification Date:
2024-10-26 @ 12:44 PM
Study NCT ID:
NCT03502876
Status:
COMPLETED
Last Update Posted:
2020-05-18
First Post:
2018-04-11
Brief Title:
Tolerance and Resistance to Ibrutinib in Patients With Chronic Lymphocytic Leukemia CLL
Sponsor:
Organization:
French Innovative Leukemia Organisation
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
True
Target Duration:
12 Months
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
collection of a blood sample
Enrollment Count:
198
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 47897 |
Who Masked List: